Aim Bulletin

hVIVO secures large whooping cough vaccine test contract

By Josh White

Date: Wednesday 22 Apr 2026

(Sharecast News) - hVIVO said on Wednesday that it has secured a contract to conduct what it described as the world's first pivotal phase three human challenge trial for a whooping cough vaccine, marking its largest study to date.
The AIM-traded group said it would run the trial for ILiAD Biotechnologies'...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page